Antimycobacterial Potential of Podocarpusflavone A from Kielmeyera membranacea
Author Information
Author(s): de Araujo Marlon Heggdorne, Muñoz Sánchez Salomé, Simão Thatiana Lopes Biá Ventura, Nowik Natalia, Antunes Stella Schuenck, Pinto Shaft Corrêa, Sorze Davide, Boldrin Francesca, Manganelli Riccardo, Correia Romeiro Nelilma, Lasunskaia Elena B., Verbeek Fons J., Spaink Herman P., Muzitano Michelle Frazão, Sherwin Catherine, Enioutina Elena Y., Job Kathleen M.
Primary Institution: Laboratório de Produtos Bioativos (LPBio), Instituto de Ciências Farmacêuticas, Universidade Federal do Rio de Janeiro
Hypothesis
This study aims to explore the antimycobacterial activity of Podocarpusflavone A isolated from Kielmeyera membranacea.
Conclusion
Podocarpusflavone A is an effective intracellular inhibitor of Mycobacterium tuberculosis and shows promise for further development as a combination drug for tuberculosis treatment.
Supporting Evidence
- Podocarpusflavone A was isolated and identified as a promising active compound.
- PCFA showed no significant toxicity to zebrafish larvae.
- PCFA inhibited Mycobacterium tuberculosis growth both extracellularly and intracellularly.
- PCFA demonstrated in vivo efficacy against M. marinum infection in zebrafish models.
- PCFA's activity was comparable to that of rifampicin at the same concentration.
Takeaway
Researchers found a natural compound from a plant that can help fight a serious lung infection called tuberculosis, and it works well with other medicines.
Methodology
The study used chromatography for fractionation, spectrometric techniques for characterization, and in vitro and in vivo tests using zebrafish models to evaluate toxicity and efficacy.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human responses.
Statistical Information
P-Value
34.38 ± 1.88 µM
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website